AAAAAA
Results: 1-25/34
Authors:
Hoyer, PF
Rodeck, B
Scherbring, M
Melter, M
Oldhafer, K
Ringe, B
Citation: Pf. Hoyer et al., Development of liver size and perfusion after reduced-size liver transplantation in children, PEDIAT TRAN, 5(3), 2001, pp. 192-197
Authors:
Biller-Andorno, N
Schauenburg, H
Ringe, B
Citation: N. Biller-andorno et al., Nondirected kidney donation from living donors, TRANSPLAN I, 14(2), 2001, pp. 125-125
Authors:
Ringe, B
Lorf, T
Dopkens, K
Canelo, R
Citation: B. Ringe et al., Treatment of hepatic metastases from gastroenteropancreatic neuroendocrinetumors: Role of liver transplantation, WORLD J SUR, 25(6), 2001, pp. 697-699
Authors:
Schwrer, H
Lorf, T
Ringe, B
Ramadori, G
Citation: H. Schwrer et al., Pantoprazole and cyclosporine or tacrolimus, ALIM PHARM, 15(4), 2001, pp. 561-562
Authors:
Braun, F
Schutz, E
Peters, B
Talaulicar, R
Grupp, C
Undre, N
Schafer, A
Armstrong, VW
Oellerich, M
Ringe, B
Citation: F. Braun et al., Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients, TRANSPLAN P, 33(3), 2001, pp. 2127-2128
Authors:
Fuller, TF
Sattler, B
Binder, L
Vetterlein, F
Ringe, B
Lorf, T
Citation: Tf. Fuller et al., Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand, TRANSPLANT, 72(2), 2001, pp. 216-222
Authors:
Ringe, B
Braun, F
Schutz, E
Fuzesi, L
Lorf, T
Canelo, R
Oellerich, M
Ramadori, G
Citation: B. Ringe et al., A novel management strategy of steroid-free immunosuppression after liver transplantation: Efficacy and safety of tacrolimus and mycophenolate mofetil, TRANSPLANT, 71(4), 2001, pp. 508-515
Authors:
von Ahsen, N
Richter, M
Grupp, C
Ringe, B
Oellerich, M
Armstrong, VW
Citation: N. Von Ahsen et al., No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin a trough concentrations or rejection incidence in stable renal transplant recipients, CLIN CHEM, 47(6), 2001, pp. 1048-1052
Authors:
Wieland, E
Shipkova, M
Schutz, E
Braun, F
Niedmann, PD
Armstrong, VW
Ringe, B
Svinarov, DA
Oellerich, M
Citation: E. Wieland et al., Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liverperfusion model, CLIN BIOCH, 34(1), 2001, pp. 53-57
Authors:
Pohanka, E
Bechstein, WO
Berlakovich, G
Binet, I
Friemann, S
Heemann, U
Kliem, V
Sperschneider, H
Stangl, M
Ringe, B
Citation: E. Pohanka et al., Prescribing and monitoring of tacrolimus in primary therapy following kidney transplantation, DEUT MED WO, 125(19), 2000, pp. 608-611
Authors:
Sattler, B
Gunawan, B
Lorf, T
Muller, D
Ringe, B
Fuzesi, L
Citation: B. Sattler et al., Undifferentiated small-cell hepatoblastoma, PATHOLOGE, 21(6), 2000, pp. 456-459
Authors:
Lorf, T
Hanack, U
Schworer, H
Sattler, B
Ringe, B
Citation: T. Lorf et al., Surgical therapy of cholangiocellular carcinomas and proximal bile duct tumors, ZBL CHIR, 125(7), 2000, pp. 637-641
Authors:
Braun, F
Lorf, T
Schutz, E
Canelo, R
Hanack, U
Dopkens, K
Sattler, B
Grupp, C
Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunological risk", TRANSPLAN P, 32(7), 2000, pp. 1688-1688
Authors:
Braun, F
Christians, U
Laabs, S
Elias, K
Shipkova, M
Schutz, E
Ringe, B
Citation: F. Braun et al., An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs, TRANSPLAN P, 32(7), 2000, pp. 1999-1999
Authors:
Braun, F
Lorf, T
Schutz, E
Canelo, R
Hanack, U
Dopkens, K
Sattler, B
Grupp, C
Ringe, B
Citation: F. Braun et al., Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk", TRANSPLAN P, 32(7), 2000, pp. 2535-2535
Authors:
Braun, F
Christians, U
Laabs, S
Elias, K
Shipkova, M
Schutz, E
Ringe, B
Citation: F. Braun et al., An ex vivo model to study the intestinal biotransformation of immunosuppressives, TRANSPLAN P, 32(7), 2000, pp. 2536-2536
Authors:
Wietzke, P
Braun, F
Ringe, B
Ramadori, G
Citation: P. Wietzke et al., Interferon alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation, TRANSPLAN P, 32(7), 2000, pp. 2539-2542
Authors:
Ringe, B
Braun, F
Wietzke, P
Oellerich, M
Ramadori, G
Citation: B. Ringe et al., Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression, TRANSPLAN P, 32(7), 2000, pp. 2543-2543
Authors:
Canelo, R
Braun, F
Dopkens, K
Ramadori, G
Ringe, B
Citation: R. Canelo et al., Characterization and influence of risk factors on initial liver function after transplantation, TRANSPLAN P, 32(1), 2000, pp. 60-61
Authors:
Braun, F
Canelo, R
Lorf, T
Schutz, E
Grupp, C
Muller, GA
Ringe, B
Citation: F. Braun et al., Living-related versus living-unrelated kidney transplantation using tacrolimus initial immunosuppression, TRANSPLAN P, 32(1), 2000, pp. 115-116
Authors:
Lorf, T
Ramadori, G
Ringe, B
Schworer, H
Citation: T. Lorf et al., The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients, EUR J CL PH, 56(5), 2000, pp. 439-440
Authors:
Lorf, T
Ramadori, G
Ringe, B
Schworer, H
Citation: T. Lorf et al., Pantoprazole does not affect cyclosporin A blood concentration in kidney-transplant patients, EUR J CL PH, 55(10), 2000, pp. 733-735
Authors:
Behr, TM
Salib, AL
Liersch, T
Behe, M
Angerstein, C
Blumenthal, RD
Fayyazi, A
Sharkey, RM
Ringe, B
Becker, H
Wormann, B
Hiddemann, W
Goldenberg, DM
Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study, CLIN CANC R, 5(10), 1999, pp. 3232S-3242S
Authors:
Lorf, T
Braun, F
Ruchel, R
Muller, A
Sattler, B
Ringe, B
Citation: T. Lorf et al., Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome (R)) after liver transplantation, MYCOSES, 42(1-2), 1999, pp. 47-53
Authors:
Schlitt, HJ
Neipp, M
Weimann, A
Oldhafer, KJ
Schmoll, E
Boeker, K
Nashan, B
Kubicka, S
Maschek, H
Tusch, G
Raab, R
Ringe, B
Manns, MP
Pichlmayr, R
Citation: Hj. Schlitt et al., Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation, J CL ONCOL, 17(1), 1999, pp. 324-331